REGULATORY COMPLIANCE – Page 31

Validation gaps identified during system upgrades – preventing repeat validation findings

Recognizing the signs that validation gaps may exist is crucial for timely intervention. Common symptoms on the manufacturing floor or in the lab may include:Click to read the full article.

Electronic signatures misused during system upgrade – risk-based ERES remediation

Identifying the symptoms of electronic signature misuse can help mitigate potential compliance risks. Common signals may include:Click to read the full article.

Validation gaps identified during lifecycle management – inspection evidence expectations

Recognizing early signals of validation deficiencies is crucial for timely intervention. These symptoms may manifest differently across various departments. Below are common signals that should raise red flags:Click to read…

System access controls weak during system upgrade – preventing repeat Part 11 findings

Recognizing symptoms of weak system access controls is crucial for timely intervention. Symptoms may include:Click to read the full article.

Incomplete validation lifecycle during system upgrades – CAPA and revalidation strategy

Identifying early symptoms of an incomplete validation lifecycle is crucial for timely intervention. Here are some common signals per department:Click to read the full article.

Record retention failures during system operation – 21 CFR Part 11 compliance gaps

Identifying symptoms indicative of record retention failures is crucial for prompt action. Symptoms might be observed on the production floor or within laboratory settings. Key indicators include:Click to read the…

GLP study documentation gaps during internal audit – alignment with OECD principles

Early detection of potential GLP study documentation gaps can save resources and reduce the risk of non-compliance during inspections. Below are indicators that may signal existence of documentation issues:Click to…

Validation gaps identified during system upgrades – regulatory deficiency risk

One of the first indicators that validation gaps may exist is often a collection of symptoms observed either on the production floor or within laboratory settings. Recognizing these signals early…

System access controls weak during validation lifecycle – 21 CFR Part 11 compliance gaps

Identifying symptoms of weaknesses in system access controls is vital for timely intervention. Common signals may include:Click to read the full article.

Inadequate worst-case selection during site expansion – risk-based validation alignment

“`html Addressing Inadequate Worst-Case Selection in Site Expansion: A Practical Playbook In the rapidly evolving landscape of pharmaceutical manufacturing, site expansions pose significant challenges, notably in ensuring appropriate validations are…

Hybrid paper-electronic workflows uncontrolled during validation lifecycle – CAPA and revalidation strategy

Identifying symptoms indicative of uncontrolled workflows is essential for timely intervention. Symptoms may manifest in various operational areas such as data entry inaccuracies, inconsistent documentation practices, and compliance breaches. Below…

Requalification overdue during site expansion – risk-based validation alignment

Awareness of potential signals indicating a requalification issue is paramount for effective intervention. Employees should stay vigilant for these symptoms:Click to read the full article.